Electronic Nudges to Increase Influenza Vaccination in Patients With Chronic Diseases
Authors: Johansen Niklas Dyrby , Vaduganathan Muthiah , Bhatt Ankeet S. , Modin Daniel , Chatur Safia , Claggett Brian L. , Janstrup Kira Hyldekær , Larsen Carsten Schade , Larsen Lykke , Wiese Lothar , Dalager-Pedersen Michael , Køber Lars , Solomon Scott D. , Sivapalan Pradeesh , Jensen Jens Ulrik Stæhr , Martel Cyril Jean-Marie , Krause Tyra Grove , Biering-Sørensen Tor 
Published: October 2024

Importance

Despite strong worldwide guideline recommendations, influenza vaccination rates remain suboptimal among young and middle-aged patients with chronic diseases. Effective scalable strategies to increase vaccination are needed.

Objective

To investigate whether electronically delivered letter-based nudges informed by behavioral science could increase influenza vaccination uptake among patients aged 18 to 64 years with chronic diseases.

Design, Setting, and Participants

Nationwide pragmatic registry-based randomized clinical implementation trial conducted between September 24, 2023, and May 31, 2024, enrolling all Danish citizens aged 18 to 64 years who met criteria for free-of-charge influenza vaccination in light of preexisting chronic disease. All trial data were sourced from nationwide administrative health registries.

Intervention

Randomized in 2.45:1:1:1:1:1:1 ratio to no letter (usual care) or 6 different behaviorally informed electronic letters.

Main Outcomes and Measures

The primary end point was receipt of influenza vaccination on or before January 1, 2024, assessed in 7 prespecified coprimary comparisons (all intervention groups pooled vs usual care and each individual intervention group vs usual care). Absolute risk difference in proportions and a crude relative risk were calculated for each comparison.

Results

A total of 299 881 participants (53.2% [159 454] female, median age, 52.0 [IQR, 39.8-59.0] years) were randomized. Compared with usual care, influenza vaccination rates were higher among those receiving any intervention letter (any intervention letter, 39.6% vs usual care, 27.9%; difference, 11.7 percentage points; 99.29% CI, 11.2-12.2 percentage points; P &amp;lt; .001). Each individual letter type significantly increased influenza vaccination with the largest effect sizes observed with a repeated letter sent 10 days after the initial letter (repeated letter, 41.8% vs usual care, 27.9%; difference, 13.9 percentage points; 99.29% CI, 13.1-14.7 percentage points; P &amp;lt; .001) and a letter emphasizing potential cardiovascular benefits of vaccination (cardiovascular gain, 39.8% vs usual care, 27.9%; difference, 11.9 percentage points; 99.29% CI, 11.1-12.7 percentage points; P &amp;lt; .001). Vaccination rates were improved across major subgroups.

Conclusions and Relevance

In a nationwide randomized clinical implementation trial, electronically delivered letter-based nudges markedly increased influenza vaccination compared with usual care among young and middle-aged patients with chronic diseases. The results of this study suggest that simple, scalable, and cost-efficient electronic letter strategies may have substantial public health implications.

Trial Registration

ClinicalTrials.gov Identifier: NCT06030739